No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
669 |
4. Check minimum number of eventsNone |
669 |
5. Include endpointsNone |
669 |
6. Filter based on genotype QC (FinnGen only) |
652 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Panhypopituitarism
based on the number of shared cases.
Similar with more cases:
- Hypopituitarism
- Exclusions for E4_PCOS_BROAD
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
- Disorders of other endocrine glands
- Used for control exclusion in common control thyroid runs
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 652 | 264 | 388 |
| Unadjusted period prevalence (%) | 0.14 | 0.09 | 0.18 |
| Median age at first event (years) | 53.98 | 47.89 | 58.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 669
- Matched controls
- 6690
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB09
ATC
hydrocortisone; systemic
491.2
307.7
539
56
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
25.6
307.7
316
226
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
362.8
307.7
264
12
101
Kela drug reimbursment
Anterior pituitary hypofunction
993.3
307.7
452
14
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
854.6
307.7
336
8
H03AA01
ATC
levothyroxine sodium; systemic
47.7
307.7
581
813
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
307.7
659
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
40.4
280.9
179
60
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
842.6
244.6
226
*
H53.4
ICD-10 Finland
Visual field defects
26.5
163.1
117
53
102
Kela drug reimbursment
Diabetes insipidus
621.5
154.3
147
*
XCK00
NOMESCO Finland
Perimetry
11.8
143.5
166
182
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
16.9
119.5
105
73
H01AC01
ATC
somatropin; parenteral
180.5
116.5
119
8
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
27.4
99.2
69
28
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
343.3
90.1
89
*
E23.2
ICD-10 Finland
Diabetes insipidus
482.2
87.2
85
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.8
85.3
155
283
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
28.2
83.2
57
22
301
Kela drug reimbursment
Growth hormone
229.9
80.2
81
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
10.2
79.8
96
108
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
436.8
79.7
78
*
E23.05
ICD-10 Finland
Lack of TSH
430.4
78.6
77
*
G02CB01
ATC
bromocriptine; systemic
22.5
69.6
52
25
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
343.9
62.5
62
*
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
61.4
58
*
ZXC86
NOMESCO Finland
Use of endoscopic device
91.5
60.2
66
8
E23.03
ICD-10 Finland
Lack of ACTH
170.5
60.0
62
*
N04BC06
ATC
cabergoline; oral
117.7
60.0
64
6
121
Kela drug reimbursment
Severe hypofunction of sexual glands
14.2
58.6
55
42
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
56.9
218
724
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
22.3
56.3
42
20
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.4
56.0
70
82
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
17.6
55.2
46
28
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
8.9
53.0
69
85
E22.1
ICD-10 Finland
Hyperprolactinaemia
99.8
50.7
55
6
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
143.6
50.6
53
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
502.0
48.0
47
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
490.4
46.9
46
*
E23.0
ICD-10 Finland
Hypopituitarism
490.4
46.9
46
*
T99
ICPC
Endocr/metab/nutrit disease other
12.3
46.0
47
41
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
+∞
45.3
43
*
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
+∞
45.3
43
*
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
44.3
42
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
43.9
186
649
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
410.5
39.5
39
*
ZXC95
NOMESCO Finland
Use of surgical navigator
13.4
39.5
38
30
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.9
38.7
130
385
AA1AD
NOMESCO Finland
CT of head and brain
3.0
38.6
255
1147
N91.1
ICD-10 Finland
Secondary amenorrhoea
14.1
37.6
35
26
E23.08
ICD-10 Finland
Hypopituitarism
+∞
35.7
34
*
H47.2
ICD-10 Finland
Optic atrophy
53.0
33.9
40
8
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
33.6
32
*
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
+∞
32.6
31
*
Y28
ICPC
Limited function/disability (Y)
65.1
32.4
37
6
2542
FHL
Transasal hypophysectomy
+∞
31.5
30
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
327.5
31.1
31
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
54.2
30.6
36
7
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
28.7
233
1135
A55
ICPC
General and Unspecified, Local injection/infiltration
11.2
27.0
29
27
WVA30, ,
SPAT
4.6
26.6
66
154
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
38.5
26.4
33
9
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
26.3
172
749
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.5
25.8
100
322
TAB00
NOMESCO Finland
Lumbar puncture
4.7
25.8
62
141
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
25.3
117
420
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.3
24.8
37
53
R51.80
ICD-10 Finland
Headache
2.8
23.9
144
598
2370A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct
+∞
23.0
22
*
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
23.0
22
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
21.8
273
1575
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
118.9
21.7
23
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.9
21.0
65
179
E23.06
ICD-10 Finland
Empty sella
79.4
20.8
23
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
113.6
20.7
22
*
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
6.5
20.4
34
55
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
20.2
308
1907
WX882
NOMESCO Finland
High dependency care
5.3
19.7
41
82
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
18.9
229
1289
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
7.9
18.8
26
34
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.9
18.6
95
358
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
6.3
18.3
31
51
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
18.2
124
543
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
14.2
17.9
30
22
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
+∞
17.8
17
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.8
17.6
28
43
E03.89
ICD-10 Finland
Other specified hypothyroidism
5.0
17.5
38
79
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
16.9
89
341
CS494
NOMESCO Finland
Other visual field testing
5.6
16.8
32
59
E27.2
ICD-10 Finland
Addisonian crisis
+∞
16.7
16
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
174.2
16.6
17
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
13.2
16.3
28
22
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.2
16.3
28
22
R50.9
ICD-10 Finland
Fever, unspecified
2.4
16.2
132
625
G03FB08
ATC
dydrogesterone and estrogen; systemic
4.2
16.2
44
110
T28
ICPC
Limited function/disability (T)
12.1
16.2
29
25
G02CB03
ATC
cabergoline; oral
34.3
15.8
20
6
25310
ICD-8 Finland
Diseases of pituitary gland, Panhypopituitarismus
+∞
15.7
15
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
87.2
15.6
17
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
15.6
207
1193
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
15.4
139
688
N03AX14
ATC
levetiracetam; systemic
5.1
15.4
33
68
H02AA02
ATC
fludrocortisone; oral
16.5
15.3
24
15
ZXA10
NOMESCO Finland
Bilateral
2.3
15.3
143
717
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.3
15.2
31
61
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
15.1
104
455
-50
ICPC
Medication/prescr/renewal
3.8
15.1
47
130
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
32.5
14.9
19
6
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
14.8
192
1094
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
21.6
14.7
21
10
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.4
14.5
29
56
Z3231
NOMESCO Finland
Registered nurse
2.0
14.4
212
1261
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
14.3
134
671
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
54.5
13.9
16
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
12.4
13.7
24
20
ZXD05
NOMESCO Finland
Urgent procedure
1.9
13.6
219
1339
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
+∞
13.6
13
*
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
+∞
13.6
13
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
13.6
150
802
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
4.2
13.5
37
93
T29
ICPC
Endocr/metab/nutr sympt/compl other
5.7
13.4
25
45
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
13.4
322
2237
E66.8
ICD-10 Finland
Other obesity
3.6
13.4
46
136
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
13.1
52
169
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.5
13.1
87
374
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
12.7
46
141
104
Kela drug reimbursment
Thyroid insufficiency
3.1
12.7
54
183
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
12.6
74
299
N75
ICPC
Benign neoplasm nervous system
+∞
12.5
12
*
E23.3
ICD-10 Finland
Hypothalamic dysfunction, not elsewhere classified
+∞
12.5
12
*
G03GA01
ATC
chorionic gonadotrophin; parenteral
5.2
12.5
26
52
A50
ICPC
General and Unspecified, Medication/prescr/renewal
3.8
12.5
39
108
G03FB06
ATC
medroxyprogesterone and estrogen; systemic
3.3
11.9
46
147
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.0
11.8
55
196
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
+∞
11.5
11
*
2530A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]
+∞
11.5
11
*
SPAT1254
SPAT
Administration of medicine
2.1
11.3
114
585
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
20.4
11.2
16
8
R53
ICD-10 Finland
Malaise and fatigue
1.9
11.1
172
1030
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
44.1
10.9
13
*
G03DB01
ATC
dydrogesterone; oral
2.5
10.9
70
295
R11
ICD-10 Finland
Nausea and vomiting
2.5
10.8
73
315
G03GA02
ATC
human menopausal gonadotrophin; parenteral
5.7
10.8
20
36
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
21.9
10.7
15
7
T73
ICPC
Neoplasm endocrine other/unspecified
61.0
10.7
12
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
11.5
10.6
19
17
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.1
10.6
22
44
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
10.4
10
*
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
+∞
10.4
10
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
10.3
22
45
A41.9
ICD-10 Finland
Sepsis, unspecified
3.4
10.3
37
113
H53.2
ICD-10 Finland
Diplopia
3.6
10.0
33
95
Z2446
NOMESCO Finland
Social worker
2.6
10.0
60
245
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
9.7
46
166
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
101.4
9.4
10
*
H47.4
ICD-10 Finland
Disorders of optic chiasm
+∞
9.4
9
*
E22.80
ICD-10 Finland
Central precocious puberty
+∞
9.4
9
*
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
9.4
9
*
9350/1-C75.1
ICD-O-3
Craniopharyngioma, NOS, of pituitary gland
+∞
9.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.3
244
1690
WX402
NOMESCO Finland
General anaesthesia
1.9
9.2
142
843
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
9.2
39
132
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
9.1
97
506
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
37.2
9.0
11
*
2152
FHL
Extraction, big brain
37.2
9.0
11
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
18.9
9.0
13
7
UDM02
NOMESCO Finland
Sinoscopy
4.0
8.9
25
64
ZX114
NOMESCO Finland
Intramuscular
5.0
8.9
19
39
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
8.9
71
331
R55
ICD-10 Finland
Syncope and collapse
2.2
8.8
81
400
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.8
148
903
G47.3
ICD-10 Finland
Sleep apnoea
1.8
8.7
164
1033
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.8
8.7
26
70
A02BC02
ATC
pantoprazole; systemic
1.7
8.6
429
3478
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
10.2
8.6
16
16
E28.3
ICD-10 Finland
Primary ovarian failure
20.3
8.5
12
6
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
91.2
8.4
9
*
S50
ICPC
Skin, Medication/prescr/renewal
13.0
8.4
14
11
C75.1
ICD-10 Finland
Malignant neoplasm: Pituitary gland
+∞
8.3
8
*
E2300, D352,
ICD-10 Finland
+∞
8.3
8
*
N76
ICPC
Neoplasm nervous system unspecified
33.8
8.1
10
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
33.8
8.1
10
*
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
8.1
86
449
R51
ICD-10 Finland
Headache
2.8
8.0
41
154
Z2445
NOMESCO Finland
Psychologist
2.9
8.0
38
137
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
8.0
78
393
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
8.0
61
278
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
8.0
66
312
N97.0
ICD-10 Finland
Female infertility associated with anovulation
7.9
7.9
17
22
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
7.9
458
3814
WF099
NOMESCO Finland
Other radiotherapy
11.0
7.8
14
13
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
15.2
7.7
12
8
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
15.2
7.7
12
8
Y99
ICPC
Genital disease male other
15.2
7.7
12
8
2151
FHL
Resection, big brain
45.5
7.7
9
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
25.3
7.6
10
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
7.5
30
98
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.2
7.5
17
24
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
7.5
90
490
2159
FHL
Other measure in this category
81.0
7.4
8
*
N04BC01
ATC
bromocriptine; oral
81.0
7.4
8
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
7.4
81
427
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
7.3
43
174
E89.31
ICD-10 Finland
Postirradiation hypopituitarism
+∞
7.3
7
*
25300
ICD-8 Finland
Diseases of pituitary gland, Aeromegalia
+∞
7.3
7
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.7
7.2
39
151
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.8
7.2
22
60
N29
ICPC
Neurological sympt/complt other
4.6
7.2
17
38
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
7.2
70
353
W11
ICPC
Contraception oral
0.1
7.2
*
258
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.8
7.1
21
56
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.1
7.0
16
23
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.9
6.9
32
114
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
11.1
6.8
12
11
R06.0
ICD-10 Finland
Dyspnoea
1.6
6.8
171
1157
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
9.4
6.8
13
14
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
6.8
88
492
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
6.8
225
1629
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
16.9
6.8
10
6
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.8
6.7
20
54
SPAT1301
SPAT
No procedures
1.6
6.6
196
1380
E34.35
ICD-10 Finland
Abnormal growth retardation
12.4
6.6
11
9
SPAT1262
SPAT
Handing over of treatment supplies
1.8
6.6
113
690
N28
ICPC
Limited function/disability (N)
5.8
6.5
17
30
AA4AD
NOMESCO Finland
CT of sella turcica
70.5
6.4
7
*
2535A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus
70.5
6.4
7
*
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.8
6.4
32
119
L28
ICPC
Limited function/disability (L)
1.8
6.4
103
616
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.8
6.4
19
51
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
6.4
98
578
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.0
6.3
27
92
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
11.2
6.3
11
10
G91.1
ICD-10 Finland
Obstructive hydrocephalus
9.4
6.3
12
13
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
9.4
6.3
12
13
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
3.9
6.3
18
47
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.3
235
1741
I49.5
ICD-10 Finland
Sick sinus syndrome
2.9
6.3
28
98
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
18.2
6.3
9
5
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
6.3
6
*
Y55
ICPC
Male Genital, Local injection/infiltration
+∞
6.3
6
*
25319
ICD-8 Finland
Diseases of pituitary gland, Hypopituitarismus alia sive NUD
+∞
6.3
6
*
E89.3
ICD-10 Finland
Postprocedural hypopituitarism
+∞
6.3
6
*
G02CB04
ATC
quinagolide; oral
+∞
6.3
6
*
D35.50
ICD-10 Finland
Carotid body
+∞
6.3
6
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
6.3
105
636
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
26.9
6.2
8
*
A06AD11
ATC
lactulose; oral
1.8
6.2
92
536
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
6.2
31
116
G44.2
ICD-10 Finland
Tension-type headache
1.9
6.1
85
486
ZXE00
NOMESCO Finland
One hour or less
1.5
6.1
235
1752
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
6.1
57
284
M05BA04
ATC
alendronic acid; oral
2.3
6.0
47
217
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
6.0
58
292
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
345
176
39.41
307.65
4.2
1.4
511.22
267.29
mu/l
1.62
334
163
473
497
30.07
307.65
6.3
1.8
244.11
373.37
nmol/l
9.96
441
455
316
49
121.32
307.65
3.9
1.9
13.58
24.27
nmol/l
6.47
309
44
127
14
111.74
247.16
2.7
2.1
0.79
1.04
ug/l
0.23
119
14
328
547
10.80
211.12
6.1
2.2
13.41
13.23
nmol/l
0.12
307
496
198
181
15.12
195.88
2.2
1.5
4.79
8.97
u/l
2.88
134
144
83
10
94.61
158.41
2.3
1.6
—
—
—
0
0
208
290
9.96
150.45
3.3
3.4
4.05
4.63
pmol/l
8.18
194
258
101
56
21.06
128.63
2.4
1.3
287.54
281.02
mosm/kgh2o
1.02
90
40
141
189
9.19
103.22
2.0
1.5
9.50
20.92
iu/l
4.71
100
158
108
157
8.01
72.91
3.2
1.8
196.59
226.34
pmol/l
0.95
97
148
55
39
15.28
61.11
1.6
1.6
—
—
—
0
0
609
3954
7.02
58.16
9.8
3.6
15.19
14.75
pmol/l
3.39
597
3578
465
2571
3.65
53.64
9.9
7.4
1.20
1.21
mmol/l
1.53
371
2213
433
2337
3.42
50.94
9.4
6.6
1.20
1.21
mmol/l
1.95
412
2146
62
72
9.39
49.85
2.4
1.5
0.30
0.28
nmol/l
0.10
45
57
42
47
9.47
34.55
2.2
1.3
—
—
—
0
0
60
108
6.00
32.49
2.0
1.5
910.72
1160.10
e6/l
0.09
53
87
60
108
6.00
32.49
2.0
1.5
40.89
52.84
e6/l
0.09
53
85
351
2015
2.56
31.18
3.4
2.3
78.06
75.01
nmol/l
1.28
329
1802
474
3179
2.68
29.72
7.9
5.0
6.37
6.76
mmol/l
4.02
458
2987
119
404
3.37
28.38
4.7
3.6
1.22
1.22
mmol/l
0.75
112
352
153
624
2.88
26.47
10.3
8.8
0.70
1.05
mmol/l
0.69
116
490
151
630
2.80
24.91
10.4
8.7
5.03
5.07
kpa
0.25
140
605
151
631
2.80
24.83
10.4
8.7
14.03
12.28
kpa
3.10
140
608
179
847
2.52
22.72
4.4
3.8
0.84
0.81
mmol/l
2.78
169
803
348
2207
2.20
22.01
5.6
5.2
34.87
35.68
g/l
1.86
333
2072
267
1573
2.16
19.82
2.6
2.2
225.86
333.29
u/l
0.85
248
1488
84
288
3.19
19.43
7.1
11.3
24.17
24.49
mmol/l
0.66
84
282
302
1908
2.06
18.25
3.5
3.2
—
—
—
0
0
148
709
2.40
17.85
6.1
6.5
1.00
1.04
mmol/l
1.37
141
658
119
520
2.57
17.48
4.1
3.3
—
—
—
0
0
263
1616
2.03
16.82
3.5
3.3
44.84
98.99
e6/l
0.64
211
1244
519
4064
2.24
16.80
9.6
7.8
79.88
78.90
u/l
0.15
505
3838
585
4833
2.68
16.58
7.5
4.3
0.95
2.16
mu/l
5.73
500
4425
99
407
2.68
16.40
3.0
2.5
10.05
10.79
g/l
0.95
82
374
95
385
2.71
16.18
2.0
1.6
—
—
—
0
0
241
1470
2.00
15.46
3.5
3.1
0.61
0.49
e6/l
0.23
192
1106
144
723
2.26
15.39
2.3
2.5
25.30
23.15
%
0.91
132
627
384
2772
1.90
14.60
7.2
6.7
11.51
11.74
umol/l
0.09
365
2639
221
1331
1.99
14.53
2.2
2.2
2.95
3.02
mg/l
0.18
200
1151
332
2296
1.89
14.33
3.0
2.7
151.51
141.17
ug/l
0.36
313
2121
221
1341
1.97
14.15
4.3
4.1
91.35
89.32
%
0.59
215
1316
147
774
2.15
13.84
2.4
2.5
2.22
2.34
g/l
1.49
135
722
282
1870
1.88
13.71
4.0
3.7
25.36
110.64
e6/l
2.69
218
1323
24
20
12.40
13.68
2.8
1.3
—
—
—
0
0
125
621
2.25
13.58
2.2
2.7
1.87
1.75
%
0.55
106
569
349
2485
1.85
13.43
11.9
15.0
1.10
1.28
inr
6.25
136
715
111
529
2.32
13.29
13.0
9.2
123.94
122.26
g/l
0.39
103
517
153
835
2.08
13.05
2.4
2.5
13.25
13.28
umol/l
0.02
142
784
117
576
2.25
12.96
12.5
9.1
95.99
95.55
%
0.24
109
557
39
106
3.85
12.82
2.5
2.6
15.84
15.92
%
0.03
24
54
188
1113
1.96
12.73
3.0
2.5
4.63
4.47
e6/l
0.09
177
998
409
3115
1.81
12.07
9.7
9.2
4.49
4.11
e9/l
2.05
369
2739
84
374
2.42
11.67
5.8
4.0
2.23
1.62
mmol/l
1.42
66
277
568
4864
2.11
10.97
6.6
5.7
39.73
40.16
mmol/mol
0.48
544
4522
432
3420
1.74
10.39
5.0
4.1
631.88
2665.47
e6/l
—
8
55
215
1403
1.78
10.39
4.4
3.6
0.00
0.01
estimate
0.69
97
475
45
155
3.04
10.28
1.4
1.1
—
—
—
0
0
288
2049
1.71
10.20
4.6
3.7
27.10
45.86
ng/l
2.33
223
1433
147
857
1.92
10.17
2.4
1.9
—
—
—
0
0
349
2621
1.69
10.06
3.8
3.5
0.00
0.01
estimate
0.50
98
468
76
346
2.35
10.03
16.1
7.8
24.21
24.10
mmol/l
0.11
68
329
315
2305
1.69
9.99
5.6
4.8
1.62
2.53
ug/l
3.83
290
2059
100
513
2.12
9.87
4.9
4.4
2.24
1.86
mmol/l
0.68
81
412
33
96
3.56
9.86
3.7
3.2
4.13
4.59
e9/l
0.52
33
96
345
2599
1.68
9.70
4.0
3.4
0.00
0.00
estimate
0.50
102
520
347
2620
1.67
9.66
7.4
6.1
29.19
27.82
%
1.19
333
2479
33
99
3.45
9.42
4.2
3.6
55.85
57.70
%
0.31
33
99
243
1681
1.70
9.35
3.5
2.7
53.12
107.41
u/l
0.60
228
1570
342
2591
1.65
9.25
5.0
4.7
0.00
0.00
estimate
-0.00
98
497
338
2576
1.63
8.75
6.9
5.9
55.52
57.08
%
1.26
324
2443
572
5017
1.97
8.75
21.5
13.0
80.91
82.61
ml/min/173m2
1.05
522
4149
53
219
2.54
8.62
2.8
2.0
4.91
2.91
ug/l
0.47
48
197
39
138
2.94
8.52
1.5
1.8
—
—
—
0
0
20
48
4.26
7.78
1.1
1.1
—
—
—
0
0
599
5389
2.07
7.76
22.9
14.3
23.28
24.52
mg/l
0.47
528
4256
579
5156
1.91
7.64
5.3
4.5
5.61
5.98
mmol/l
14.07
558
4707
466
3916
1.63
7.54
4.9
4.0
11.21
11.35
mm/h
0.07
448
3607
67
331
2.14
7.26
1.3
1.4
—
—
—
0
0
36
134
2.78
7.20
1.6
1.8
—
—
—
0
0
10
5
20.27
7.15
1.3
1.0
—
—
—
0
0
20
52
3.93
7.02
1.1
1.1
—
—
—
0
0
271
2037
1.56
6.94
4.2
3.5
—
—
—
0
0
103
604
1.83
6.84
3.0
4.3
229.44
249.38
u/l
0.89
95
573
56
268
2.19
6.58
3.5
3.4
25.22
24.86
mmol/l
0.37
51
261
240
1775
1.55
6.52
3.2
3.5
47.56
33.29
u/l
0.76
230
1696
183
1279
1.59
6.33
2.5
2.5
—
—
—
0
0
84
478
1.87
6.13
8.5
8.4
1.47
1.45
mmol/l
0.04
84
465
196
1411
1.55
5.91
1.8
1.7
1.65
1.42
mmol/l
2.74
170
1191
15
26
5.87
5.86
1.3
1.0
—
—
—
0
0
99
601
1.76
5.84
2.0
1.8
—
—
—
0
0
16
41
3.97
5.74
1.3
1.6
—
—
—
0
0
41
185
2.30
5.56
1.3
1.3
0.29
1.93
u/ml
—
7
15
13
21
6.29
5.40
1.0
1.1
—
—
—
0
0
16
43
3.79
5.39
1.1
1.1
—
—
—
0
0
17
491
0.33
5.35
1.5
1.7
—
—
—
0
0
265
2079
1.45
5.12
2.1
1.9
100.78
93.75
pmol/l
1.47
151
1094
22
76
2.96
5.07
1.3
1.7
—
—
—
0
0
225
1713
1.47
5.06
4.4
3.5
2.32
2.35
mmol/l
2.49
210
1526
127
858
1.59
4.97
3.1
3.0
2.56
1.70
e6/l
0.68
68
476
11
16
6.97
4.97
3.4
1.3
305.00
64.75
nmol/24h
0.79
11
16
19
61
3.18
4.95
1.6
1.7
34.16
33.08
pg
0.52
19
61
308
2510
1.42
4.73
2.9
2.6
—
—
—
0
0
553
5038
1.56
4.57
4.7
3.9
1.60
1.32
mmol/l
5.83
524
4644
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
23
5.29
4.47
1.1
1.2
—
—
—
0
0
22
82
2.74
4.46
1.2
1.3
—
—
—
0
0
23
88
2.67
4.44
1.3
1.6
—
—
—
0
0
94
606
1.64
4.44
2.1
1.9
—
—
—
0
0
25
100
2.56
4.43
1.6
1.9
—
—
—
0
0
18
61
3.00
4.31
1.2
1.8
—
—
—
0
0
129
905
1.53
4.25
2.9
2.8
0.79
0.95
e6/l
0.37
71
517
162
1193
1.47
4.21
1.4
1.3
0.72
1.31
u/ml
1.46
48
321
12
25
4.87
4.20
1.2
1.0
1.53
1.11
u/l
—
7
16
48
259
1.92
4.15
7.4
4.5
25.44
24.81
mmol/l
1.01
48
248
132
937
1.51
4.11
1.9
1.7
1286.57
1169.66
nmol/l
0.75
102
711
79
497
1.67
4.10
2.4
2.4
0.21
0.22
g/l
0.39
74
460
21
81
2.64
4.01
1.4
1.3
9.22
6.54
u/ml
—
9
41
233
1849
1.40
4.00
4.8
4.2
22.14
21.16
%
0.47
113
849
12
27
4.51
3.95
1.2
1.8
—
—
—
0
0
609
5722
1.72
3.94
13.6
10.3
30.20
27.88
u/l
2.14
599
5534
567
5243
1.53
3.86
5.2
4.4
4.50
4.59
mmol/l
1.27
542
4882
145
1062
1.47
3.85
1.8
1.7
442.92
10948499.63
pmol/l
0.79
119
886
564
5211
1.52
3.84
5.2
4.3
1.29
1.41
mmol/l
11.48
538
4817
12
28
4.34
3.83
1.2
1.7
—
—
—
0
0
196
1524
1.40
3.75
3.2
3.2
1663.02
1410.15
ng/l
0.25
170
1298
10
20
5.06
3.70
1.1
1.2
—
1.06
—
0
7
23
97
2.42
3.69
1.7
1.8
—
—
—
0
0
23
97
2.42
3.69
1.7
1.8
—
—
—
0
0
44
241
1.88
3.66
17.0
6.8
1.60
1.61
%
0.01
39
226
574
5336
1.53
3.66
5.6
4.8
2.70
2.73
mmol/l
0.44
550
4926
23
99
2.37
3.54
1.3
1.7
—
—
—
0
0
8
14
5.77
3.35
1.0
1.1
—
—
—
0
0
8
14
5.77
3.35
1.0
1.1
—
—
—
0
0
12
33
3.68
3.30
4.2
2.2
—
—
—
0
0
12
33
3.68
3.30
1.2
1.7
—
—
—
0
0
161
1235
1.40
3.29
1.8
1.5
18.82
20.44
nmol/l
0.71
145
1047
19
78
2.48
3.24
1.2
1.7
—
—
—
0
0
8
15
5.38
3.20
1.0
1.3
—
—
—
0
0
8
15
5.38
3.20
1.0
1.2
—
—
—
0
0
11
29
3.84
3.19
1.1
1.1
—
—
—
0
0
19
79
2.45
3.16
1.1
1.1
—
—
—
0
0
11
30
3.71
3.09
2.2
3.4
97.82
97.93
%
0.00
11
30
59
372
1.64
3.07
3.6
4.4
80.13
84.00
ng/l
0.14
52
338
124
922
1.42
3.01
3.8
3.2
2.44
2.44
mmol/l
0.29
110
817
6
196
0.30
2.97
1.7
1.5
—
—
—
0
0
41
237
1.78
2.92
1.4
2.0
1.38
1.46
g/l
0.25
36
211
152
1182
1.37
2.83
1.9
1.9
1.70
1.28
mg/l
0.46
114
902
6
10
6.04
2.70
1.0
1.3
—
—
—
0
0
32
176
1.86
2.68
1.9
2.1
—
—
—
0
0
9
24
3.79
2.68
1.2
1.3
—
—
—
0
0
34
191
1.82
2.67
2.7
1.8
—
—
—
0
0
628
6034
1.67
2.61
34.4
20.8
40.83
40.61
%
0.43
602
5655
29
156
1.90
2.61
2.5
1.7
—
—
—
0
0
7
15
4.70
2.60
1.0
1.1
—
—
—
0
0
12
44
2.76
2.56
1.5
1.5
37.51
184.88
pmol/l
10.64
12
44
15
62
2.45
2.55
1.3
1.2
—
—
—
0
0
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
628
6038
1.65
2.55
34.2
20.6
249.12
246.77
e9/l
0.40
620
5882
86
619
1.45
2.50
2.5
3.0
6.70
8.92
umol/l
1.12
75
548
628
6042
1.64
2.49
34.3
20.6
4.58
4.55
e12/l
0.68
621
5873
167
1343
1.32
2.48
3.7
2.9
0.59
0.74
ug/l
3.44
131
851
42
657
0.62
2.44
1.7
2.1
—
—
—
0
0
126
983
1.35
2.29
3.7
3.9
131.53
442.64
ng/l
1.89
88
767
13
53
2.48
2.29
2.2
2.4
—
—
—
0
0
33
194
1.74
2.27
1.9
2.5
—
—
—
0
0
17
79
2.18
2.26
1.3
1.7
—
—
—
0
0
48
312
1.58
2.26
1.1
1.3
—
44.80
—
0
19
7
18
3.92
2.25
2.9
4.7
—
—
—
0
0
32
187
1.75
2.25
2.5
3.0
—
—
—
0
0
5
9
5.59
2.21
1.0
4.7
—
—
—
0
0
12
48
2.53
2.19
1.8
2.7
—
—
—
0
0
15
67
2.27
2.19
1.3
1.7
—
—
—
0
0
15
67
2.27
2.19
1.3
1.7
—
—
—
0
0
14
61
2.32
2.16
2.4
2.3
—
—
—
0
0
29
167
1.77
2.15
3.2
3.4
3.32
3.58
g/l
0.53
29
161
34
206
1.69
2.12
3.2
1.9
—
—
—
0
0
12
49
2.48
2.11
1.5
1.3
—
—
—
0
0
11
43
2.58
2.08
2.1
2.2
583.33
658.17
ml
—
6
24
46
305
1.55
2.01
2.1
1.6
—
—
—
0
0
48
323
1.52
1.97
1.3
1.2
81.63
145.46
iu/ml
0.78
18
137
7
21
3.36
1.97
2.4
1.3
—
—
—
0
0
6
16
3.77
1.94
2.0
1.8
—
—
—
0
0
15
71
2.14
1.93
1.1
1.2
—
—
—
0
0
28
166
1.72
1.90
3.6
4.1
41.27
35.62
mg/l
0.13
23
136
23
130
1.80
1.83
1.8
1.9
284.15
6.01
iu/l
0.46
11
42
16
80
2.02
1.81
1.5
1.3
3.00
5.07
u/ml
—
5
27
9
35
2.59
1.80
2.2
1.7
89.33
79.74
umol/l
—
9
35
5
13
3.87
1.72
3.8
1.6
—
—
—
0
0
12
55
2.20
1.68
2.0
1.8
—
—
—
0
0
12
55
2.20
1.68
2.0
1.8
—
—
—
0
0
12
55
2.20
1.68
2.0
1.8
—
—
—
0
0
67
498
1.38
1.67
2.6
2.4
35.47
33.45
u/l
0.11
57
422
18
97
1.88
1.67
1.1
1.1
1.83
93.70
iu/ml
—
6
21
8
31
2.60
1.66
2.4
2.0
—
—
—
0
0
8
31
2.60
1.66
2.4
2.0
—
—
—
0
0
42
601
0.68
1.66
1.7
2.0
—
—
—
0
0
18
98
1.86
1.63
1.2
1.1
—
—
—
0
0
25
152
1.67
1.58
1.3
1.5
257.74
289.20
ug/g
0.25
12
91
27
168
1.63
1.57
2.5
1.7
—
—
—
0
0
179
1537
1.22
1.51
3.0
3.3
1667.59
214.79
mg/l
1.33
118
1037
6
21
2.87
1.51
3.7
3.1
—
—
—
0
0
6
21
2.87
1.51
3.7
3.1
—
—
—
0
0
18
101
1.80
1.50
1.2
1.3
—
—
—
0
0
18
101
1.80
1.50
1.2
1.3
—
—
—
0
0
12
58
2.09
1.50
2.4
2.1
—
—
—
0
0
21
124
1.72
1.48
1.3
1.5
—
—
—
0
0
19
109
1.76
1.48
1.6
1.5
—
—
—
0
0
5
16
3.14
1.44
1.4
1.0
916.80
1424.75
miu/ml
—
5
16
6
23
2.62
1.37
1.2
1.0
—
—
—
0
0
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
6
23
2.62
1.37
1.0
1.1
93.67
186.10
iu/ml
—
6
23
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
168
1.57
1.33
6.2
2.9
0.29
0.35
u/ml
0.70
18
89
6
24
2.51
1.30
1.3
3.4
34.17
35.35
umol/l
—
6
17
55
416
1.35
1.28
3.3
3.0
137.77
201.32
ng/l
0.80
48
375
8
35
2.30
1.27
1.1
1.3
7.28
9.15
u/l
—
8
27
19
115
1.67
1.26
2.9
3.8
22.16
27.90
mg/l
0.51
12
73
139
1186
1.22
1.25
4.0
3.6
1.01
1.02
kg/l
1.21
16
173
6
25
2.41
1.24
2.7
2.1
—
—
—
0
0
6
25
2.41
1.24
2.7
2.1
—
—
—
0
0
81
997
0.79
1.23
1.4
1.5
—
—
—
0
0
12
63
1.92
1.23
2.5
2.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
19
2.64
1.22
1.0
2.7
208.60
133.00
%
—
5
19
6
26
2.32
1.19
2.8
2.1
—
—
—
0
0
8
38
2.12
1.18
1.1
1.2
—
—
—
0
0
376
3508
1.16
1.16
2.9
3.1
—
—
—
0
0
191
1694
1.18
1.12
3.1
3.2
7.99
8.10
mmol/l
0.11
170
1438
8
40
2.01
1.12
3.3
1.2
—
—
—
0
0
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
8
41
1.96
1.09
3.3
1.3
—
—
—
0
0
58
463
1.28
0.96
3.4
2.5
4.00
7.11
ug/l
2.25
50
417
21
141
1.51
0.96
1.5
1.7
—
—
—
0
0
51
401
1.29
0.95
3.4
2.7
65.68
68.28
ml/min/173m2
0.18
28
162
9
51
1.77
0.95
1.6
1.1
—
—
—
0
0
40
305
1.33
0.93
2.6
2.7
0.23
0.18
e6/l
0.24
40
294
387
3659
1.14
0.89
4.2
3.3
65.50
50.50
u/l
2.43
366
3442
8
43
1.87
0.87
1.0
1.0
323.50
285.26
mg/l
—
8
38
8
44
1.83
0.86
1.4
1.2
—
—
—
0
0
6
31
1.94
0.84
1.2
1.3
—
—
—
0
0
14
212
0.65
0.81
1.6
1.9
—
—
—
0
0
19
270
0.70
0.80
1.2
1.9
—
—
—
0
0
99
856
1.18
0.80
1.3
1.3
24.70
34.33
iu/ml
0.76
21
267
6
33
1.83
0.79
2.0
1.3
—
—
—
0
0
23
165
1.41
0.78
1.2
1.2
—
—
—
0
0
5
24
2.09
0.74
2.0
2.2
—
—
—
0
0
5
24
2.09
0.74
1.8
2.1
—
—
—
0
0
20
142
1.42
0.73
1.2
1.1
—
—
—
0
0
5
25
2.01
0.73
3.6
2.8
43160.00
40212.20
ug/l
—
5
25
9
56
1.62
0.72
1.2
1.1
1.99
1.64
nmol/l
—
9
51
10
60
1.68
0.72
1.2
1.1
—
—
—
0
0
9
57
1.59
0.71
9.1
1.9
12.81
13.17
%
—
9
57
23
169
1.37
0.70
1.2
1.1
—
—
—
0
0
20
144
1.40
0.68
1.3
1.2
—
2.93
—
0
6
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
18
128
1.42
0.66
1.3
1.3
—
—
—
0
0
21
281
0.74
0.65
1.1
1.0
—
—
—
0
0
17
120
1.43
0.65
1.9
1.4
—
—
—
0
0
178
1634
1.12
0.64
3.9
3.9
6.64
9.82
mg/mmol
0.64
111
1082
36
289
1.26
0.62
1.4
1.3
—
—
—
0
0
8
49
1.64
0.62
1.1
1.0
—
—
—
0
0
93
820
1.16
0.62
1.2
1.3
3.21
12.51
u/ml
2.37
34
329
10
152
0.65
0.61
1.4
1.3
—
—
—
0
0
8
50
1.61
0.61
1.1
2.0
—
—
—
0
0
21
157
1.35
0.59
2.5
2.3
39.42
106.04
ug/min
1.03
12
91
8
54
1.49
0.57
1.1
1.4
—
—
—
0
0
5
86
0.58
0.56
2.2
1.6
—
—
—
0
0
26
328
0.78
0.55
1.5
2.0
—
—
—
0
0
72
629
1.16
0.55
16.1
7.2
—
—
—
0
0
16
120
1.34
0.46
1.2
1.2
—
—
—
0
0
5
82
0.61
0.46
1.0
1.1
—
—
—
0
0
18
138
1.31
0.46
1.3
1.2
—
13.93
—
0
23
8
121
0.66
0.45
1.0
1.2
—
—
—
0
0
152
1413
1.10
0.44
2.8
2.9
362.82
6616.88
umol/l
5.06
132
1244
10
69
1.46
0.44
2.2
1.4
—
—
—
0
0
10
70
1.44
0.42
2.2
1.4
—
—
—
0
0
10
70
1.44
0.42
2.2
1.4
—
—
—
0
0
10
70
1.44
0.42
2.2
1.4
—
—
—
0
0
5
33
1.52
0.41
1.0
1.0
299.80
249.30
ng/l
—
5
20
5
33
1.52
0.41
1.0
1.0
642.00
515.95
ng/l
—
5
20
5
33
1.52
0.41
1.0
1.0
60.80
35.94
ng/l
—
5
18
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
10
71
1.41
0.39
2.2
1.4
—
—
—
0
0
10
71
1.41
0.39
2.2
1.4
—
—
—
0
0
6
47
1.28
0.32
1.0
1.4
—
—
—
0
0
13
101
1.29
0.32
1.0
1.2
13.46
32.34
u/l
0.82
13
90
9
72
1.25
0.25
1.1
1.0
—
—
—
0
0
5
42
1.19
0.21
1.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
19.25
—
0
12
0
14
0.00
0.20
0.0
1.6
—
39.57
—
0
14
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
16
136
1.18
0.20
1.4
1.4
—
—
—
0
0
57
611
0.93
0.19
1.4
1.4
—
—
—
0
0
20
175
1.15
0.18
1.8
2.1
—
6122.67
u/l
—
0
62
12
102
1.18
0.15
1.5
1.7
—
—
—
0
0
49
522
0.93
0.15
3.7
4.5
100.41
36.25
ug/l
0.30
34
434
13
116
1.12
0.09
1.5
1.4
—
—
—
0
0
71
729
0.97
0.06
1.5
1.9
1.48
1.50
%
0.13
62
644
15
140
1.07
0.04
1.3
1.3
—
—
—
0
0
10
107
0.93
0.02
1.5
1.2
—
38.48
—
0
8
11
112
0.98
0.00
2.3
1.7
—
—
—
0
0
18
182
0.99
0.00
1.3
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
7.60
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
0.40
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: E4_PANHYPOPITUITARISM – Panhypopituitarism
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).